Table 2 Cardiometabolic risk parameters (median, IQR)

 Fasting glucose (mg/dL)

85, 80–90

86, 81–92

0.4

 OGTT 2-h glucose (mg/dL)

114, 95–133

119, 98–134

0.6

 Fasting insulin (uU/mL)

14, 9–18

8, 5–10

< 0.0001^†*^#

 HOMA-IR

2.6, 1.7–3.7

1.5, 1.0–2.2

< 0.0001^†*^#

 Total cholesterol (mg/dL)

172, 151–194

177, 156–202

0.2

 HDL cholesterol (mg/dL)

38, 33–43

51, 43–59

< 0.0001^†*^#

 LDL cholesterol (mg/dL)

107, 93–125

106, 87–128

0.7

 Triglyceride level (mg/dL)

111, 82–160

89, 69–127

0.001^†*^#

 Apolipoprotein B (ApoB) (mg/dL)

95, 84–110

85, 69–106

0.01*^#

 ApoB/LDL

0.88, 0.83–0.98

0.79, 0.70–0.87

< 0.0001^†*^#

 hsCRP (ng/L)

2.4, 1.4–6.0

2.9, 1.3–5.5

0.8

 Fibrinogen (mg/dL)

395, 344–452

475, 419–523

< 0.0001^†*^#

Metabolic syndrome (n, %)

34 (37%)

19 (17%)

0.002^†